Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2574

Dec 13, 2015

The First Human Life Extension Trial

Posted by in categories: biotech/medical, life extension

Last week the FDA announced that they have granted permission for the TAME trial. The Targeting Aging with Metformin (TAME) trial is the first human trial specifically looking at an anti-aging drug in humans.

Repurposing An Old Medicine

Metformin is an old drug, first approved in France in 1957, for the treatment of type 2 diabetes and polycystic ovary syndrome (PCOS). However extracts from the French liliac (Galega officinalis), the plant containing a precursor of metformin, has been used to treat frequent urination, a symptom of diabetes, since the Middle Ages. In 2012 in the US about 60 million prescriptions for metformin were written, making metformin the most used antidiabetic drug. Amazingly, every year about 37,000 metric tons of metformin are produced! Metformin is also a super-cheap drug, costing only cents per dose.

Read more

Dec 12, 2015

Researchers Reprogram Genome to Produce More Dopamine

Posted by in category: biotech/medical

This new development could help us in the fight against Parkinson’s.

Read more

Dec 12, 2015

How virtual reality is going to change our lives

Posted by in categories: biotech/medical, military, virtual reality

2016 will be the year of VR. Here’s how it will change everything from medicine to the military.

Read more

Dec 12, 2015

Worm research in life extension leads scientists to discover new metric to track aging

Posted by in categories: biotech/medical, evolution, life extension

C. elegans roundworm (credit: The Goldstein Lab)

When researchers at The Scripps Research Institute (TSRI) in California administered an antidepressant called mianserin to the Caenorhabditis elegans roundworm in 2007, they discovered the drug increased the lifespan of the “young adulthood” of roundworms by 30–40 per cent.

So, does that mean it will work in humans? Not necessarily. “There are millions of years of evolution between worms and humans,” says TSRI researcher Michael Petrascheck. “We may have done this in worms, but we don’t want people to get the impression they can take the drug we used in our study to extend their own teens or early twenties.”

Read more

Dec 11, 2015

University hospital performs first bionic eye transplant in Colorado

Posted by in categories: biotech/medical, cyborgs, health, transhumanism

The UCHealth Eye Center implants first bionic eye in a Colorado resident.

Read more

Dec 11, 2015

Your Attitude About Aging May Impact How You Age

Posted by in categories: biotech/medical, life extension, neuroscience

In a new study, people who believed negative stereotypes about old age had higher risk of Alzheimer’s.

Read more

Dec 11, 2015

Gene therapies to reverse human aging – Interview with entrepreneur Elizabeth Parrish

Posted by in categories: biotech/medical, life extension

This article is based on my skype conversation with Elizabeth Parrish, founder and CEO of BioViva. BioViva is a biotech company in the Seattle area focused on developing gene therapies to mitigate the diseases of aging. Liz is currently experimenting these therapies on herself. Her research was recently covered in a MIT Technology Review article and she did an AMA on Reddit you may want to check out.

Read more

Dec 11, 2015

Farma bioreactor could let owners brew drugs at home

Posted by in categories: biotech/medical, food

MIT Media Lab graduate Will Patrick has designed a prototype desktop bioreactor that could enable the production of pharmaceutical drugs at home.

The cylinder-shaped Farma kitchen appliance could be used to grow, measure, filter and dry synthetically designed microbes.

Continue reading “Farma bioreactor could let owners brew drugs at home” »

Dec 9, 2015

AI will replace smartphones within 5 years, Ericsson survey suggests

Posted by in categories: biotech/medical, mobile phones, robotics/AI

(credit: Ericsson ConsumerLab)

Artificial intelligence (AI) interfaces will take over, replacing smartphones in five years, according to a survey of more than 5000 smartphone customers in nine countries by Ericsson ConsumerLab in the fifth edition of its annual trend report, 10 Hot Consumer Trends 2016 (and beyond).

Smartphone users believe AI will take over many common activities, such as searching the net, getting travel guidance, and as personal assistants. The survey found that 44 percent think an AI system would be as good as a teacher and one third would like an AI interface to keep them company. A third would rather trust the fidelity of an AI interface than a human for sensitive matters; and 29 percent agree they would feel more comfortable discussing their medical condition with an AI system.

Read more

Dec 9, 2015

Scores of Labs Should be Gearing Up to Work on Glucosepane Cross-Link Breakers, But Are They?

Posted by in categories: biotech/medical, chemistry, health, life extension, neuroscience

Glucosepane is one of the most significant mechanisms of aging and yet very few people are working on it!


As we age skin and blood vessels lose their elasticity. People care too much about the skin and too little about the blood vessels, but that is always the way of it. Appearance first and substance later, if at all. Yet you can live inside an aged skin; beyond the raised risk of skin cancer its damaged state arguably only makes life less pleasant, and the present state of medical science can ensure that the numerous age-related dermatological dysfunctions can be kept to a state of minor inconvenience. Loss of blood vessel elasticity, on the other hand, will steadily destroy your health and then kill you. Arterial stiffening causes remodeling of the cardiovascular system and hypertension. The biological systems that regulate blood pressure become dysfunctional as blood vessels depart from ideal youthful behavior, creating a downward spiral of increasing blood pressure and reactions to that increase. Small blood vessels fail under the strain in ever larger numbers, damaging surrounding tissue. In the brain this damage contributes to age-related cognitive decline by creating countless tiny, unnoticed strokes. Ultimately this process leads to dementia. More important parts of the cardiovascular system are likely to fail first, however, perhaps causing a stroke, or a heart attack, or the slower decline of congestive heart failure.

From what is known today, it is reasonable to propose that the two main culprits driving loss of tissue elasticity are sugary cross-links generated as a byproduct of the normal operation of cellular metabolism and growing numbers of senescent cells. Elasticity is a property of the extracellular matrix, an intricate structure of collagens and other proteins created by cells. Different arrangements of these molecules produce very different structures, ranging from load-bearing tissues such as bone and cartilage to elastic tissues such as skin and blood vessel walls. Disrupting the arrangement and interaction of molecules in the extracellular matrix also disrupts its properties. Persistent cross-links achieve this by linking proteins together and restricting their normal range of motion. Senescent cells, on the other hand, secrete a range of proteins capable of breaking down or remodeling portions of the surrounding extracellular matrix, and altering the behavior of nearby cells for the worse.

Continue reading “Scores of Labs Should be Gearing Up to Work on Glucosepane Cross-Link Breakers, But Are They?” »